Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Hematology (Amsterdam, Netherlands)|February 8, 2024
Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcomeLina Z Rüsing, Nicolas Kozakowski, Georg Jeryczynski, et al.
Blood|June 30, 2005
The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patientsPhilipp S Goerttler, Cordula Steimle, Edith März, et al.
Blood|April 15, 2025
DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia veraGhaith Abu-Zeinah, Katie Erdos, Neville Lee, et al.
American Journal of Hematology|September 11, 2002
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemiaMarco Ruggeri, Heinz Gisslinger, Alberto Tosetto, et al.
British Journal of Haematology|April 10, 2013
High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasoneDaniel Heintel, Alberto Rocci, Heinz Ludwig, et al.
British Journal of Haematology|July 9, 2002
Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioningMargit Mitterbauer, Peter Kalhs, Felix Keil, et al.
Blood|December 3, 2008
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617FFranz X Schaub, Roland Jäger, Renate Looser, et al.
Genome Biology|January 30, 2016
Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humansAleksandra E Kornienko, Christoph P Dotter, Philipp M Guenzl, et al.
American Journal of Hematology|July 27, 2025
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential ThrombocythemiaTiziano Barbui, Jürgen Thiele, Arianna Ghirardi, et al.
Cancer|November 15, 2006
Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasiaKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.
Pageof 15